Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Cooper/Aspect Vision

This article was originally published in The Gray Sheet

Executive Summary

Cooper/Aspect Vision: Cooper Companies to acquire privately held contact lens maker Aspect Vision Care under a non-binding letter of intent agreement announced Sept. 3. Southampton, England-based Aspect is anticipated to generate $45-50 mil. in revenues "in its first full year with CooperVision," Cooper's specialty contact lens business, Cooper says. Aspect, which markets its lenses primarily in the United Kingdom and other European countries, "would provide CooperVision with an ideal platform to launch our specialty lens product line into the European market," stated Thomas Bender, Cooper CEO and president of CooperVision. In addition, CooperVision, which markets its lenses "predominantly in North America...would be able to offer Aspect's full range of traditional and frequent replacement products to practitioners in selected market niches in our dominant territories," Bender said. Terms were not disclosed...

You may also be interested in...



Cosmetics Weekly Trademark Review: 14 January 2020

Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.

Cosmetics Weekly Trademark Review: 7 January 2020

Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.

OTC Codeine Is 'Safe And Effective' – UK Industry Responds To BBC Exposé

Will the UK follow other countries and reverse-switch codeine to prescription-only status? British industry association, the PAGB, responds to a BBC documentary questioning the safety and efficacy of OTC codeine.
UsernamePublicRestriction

Register

MT008712

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel